title: Response to commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
authors.forename: J S
authors.initials: JS
authors.lastname: Patterson
authors.forename: P V
authors.initials: PV
authors.lastname: Plourde
authors.forename: A
authors.initials: A
authors.lastname: Milbauer
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002423:Cause of Death; D002986:Clinical Trials as Topic; D016889:Endometrial Neoplasms / Q000401:mortality*; D005260:Female; D006801:Humans; D016609:Neoplasms, Second Primary / Q000401:mortality*; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen